• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by Kucheman William

    12/15/21 8:40:40 PM ET
    $HRC
    Medical/Dental Instruments
    Health Care
    Get the next $HRC alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
    X
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    1. Name and Address of Reporting Person*
    Kucheman William

    (Last) (First) (Middle)
    130 EAST RANDOLPH STREET
    SUITE 1000

    (Street)
    CHICAGO IL 60601

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Hill-Rom Holdings, Inc. [ HRC ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    12/13/2021
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 0 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Stock Units (03/11/2013) (1) 12/13/2021 D 4,567 (2) (2) Common Stock 4,567 (2) 0 D
    Restricted Stock Units (03/07/2014) (1) 12/13/2021 D 4,262 (2) (2) Common Stock 4,262 (2) 0 D
    Restricted Stock Units (03/05/2015) (1) 12/13/2021 D 3,339 (2) (2) Common Stock 3,339 (2) 0 D
    Restricted Stock Units (03/16/2016) (1) 12/13/2021 D 3,385 (2) (2) Common Stock 3,385 (2) 0 D
    Restricted Stock Units (09/19/2016) (1) 12/13/2021 D 176 (2) (2) Common Stock 176 (2) 0 D
    Restricted Stock Units (03/14/2017) (1) 12/13/2021 D 2,762 (2) (2) Common Stock 2,762 (2) 0 D
    Restricted Stock Units (03/07/2018) (1) 12/13/2021 D 2,184 (2) (2) Common Stock 2,184 (2) 0 D
    Restricted Stock Units (03/06/2019) (1) 12/13/2021 D 1,762 (2) (2) Common Stock 1,762 (2) 0 D
    Restricted Stock Units (02/26/2020) (1) 12/13/2021 D 1,870 (2) (2) Common Stock 1,870 (2) 0 D
    Restricted Stock Units (03/11/2021) (1) 12/13/2021 D 1,798 (2) (2) Common Stock 1,798 (2) 0 D
    Explanation of Responses:
    1. Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock.
    2. Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock.
    Remarks:
    /s/ Ari Mintzer as Attorney-in-Fact for William H. Kucheman 12/15/2021
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $HRC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HRC

    DatePrice TargetRatingAnalyst
    9/20/2021$148.00 → $156.00Overweight → Equal-Weight
    Morgan Stanley
    9/8/2021Overweight → Sector Weight
    Keybanc
    9/3/2021$150.00 → $156.00Outperform → Neutral
    Baird
    8/10/2021$130.00Buy → Neutral
    B of A Securities
    8/10/2021Buy → Neutral
    BofA Securities
    8/2/2021$131.00 → $145.00Overweight
    Keybanc
    More analyst ratings

    $HRC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Alcoa Set to Join S&P MidCap 400

      NEW YORK, Dec. 13, 2021 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400: Alcoa Corp. (NYSE:AA) will replace Hill-Rom Holdings Inc. (NYSE:HRC) in the S&P MidCap 400 effective prior to the opening of trading on Monday, December 20. S&P 500 constituent Baxter International Inc. (NYSE:BAX) is acquiring Hill-Rom in a deal that was completed today. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector December 20, 2021 S&P MidCap 400 Addition Alcoa AA Materials S&P MidCap 400 Deletion Hill-Rom Holdings HRC Health Care For more

      12/13/21 7:20:00 PM ET
      $AA
      $BAX
      $HRC
      $SPGI
      Aluminum
      Industrials
      Medical/Dental Instruments
      Health Care
    • Hillrom Shareholders Approve Acquisition By Baxter

      CHICAGO, Dec. 2, 2021 /PRNewswire/ -- Hillrom (NYSE:HRC) today announced that its shareholders have voted to approve the previously announced pending acquisition by Baxter International Inc. (NYCE: BAX) at a special meeting. Hillrom shareholders voted overwhelmingly in favor of the transaction. Under the terms of the merger agreement, Hillrom shareholders will receive $156.00 per share in cash for every share of Hillrom stock they own immediately prior to the effective time of the merger. "The strong support of our investors over the years and in today's shareholder vote is an

      12/2/21 5:48:00 PM ET
      $BAX
      $HRC
      Medical/Dental Instruments
      Health Care
    • Hillrom Exceeds Fourth Quarter Guidance With Strong Finish To Fiscal Year

      CHICAGO, Nov. 5, 2021 /PRNewswire/ -- Hillrom (NYSE:HRC) today announced financial results for its fiscal fourth quarter and full-year ended September 30, 2021. For the fiscal fourth quarter, Hillrom reported GAAP earnings of $0.80 per diluted share, an increase of 27 percent compared to $0.63 per diluted share in the prior-year period. On an adjusted basis, excluding special items, earnings of $1.67 per diluted share increased 43 percent and exceeded the company's previously-issued guidance range of $1.44 to $1.48 per diluted share. Adjustments to reported earnings are detail

      11/5/21 6:59:00 AM ET
      $HRC
      Medical/Dental Instruments
      Health Care

    $HRC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Hill-Rom Holdings Inc (Amendment)

      SC 13G/A - Hill-Rom Holdings, Inc. (0000047518) (Subject)

      10/8/21 8:36:46 AM ET
      $HRC
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Hill-Rom Holdings Inc (Amendment)

      SC 13G/A - Hill-Rom Holdings, Inc. (0000047518) (Subject)

      6/10/21 10:06:36 AM ET
      $HRC
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed

      SC 13G/A - Hill-Rom Holdings, Inc. (0000047518) (Subject)

      2/10/21 10:57:20 AM ET
      $HRC
      Medical/Dental Instruments
      Health Care

    $HRC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Groetelaars John P returned 34,870 shares to the company, closing all direct ownership in the company

      4 - Hill-Rom Holdings, Inc. (0000047518) (Issuer)

      12/15/21 8:41:20 PM ET
      $HRC
      Medical/Dental Instruments
      Health Care
    • SEC Form 4: Frank Andreas G returned 16,539 shares to the company, closing all direct ownership in the company

      4 - Hill-Rom Holdings, Inc. (0000047518) (Issuer)

      12/15/21 8:41:21 PM ET
      $HRC
      Medical/Dental Instruments
      Health Care
    • SEC Form 4: Giertz James R returned 2,000 shares to the company, closing all direct ownership in the company

      4 - Hill-Rom Holdings, Inc. (0000047518) (Issuer)

      12/15/21 8:41:15 PM ET
      $HRC
      Medical/Dental Instruments
      Health Care

    $HRC
    Leadership Updates

    Live Leadership Updates

    See more
    • Amy Salzhauer And Greg Miller Join The Board Of ABM Respiratory Care

      SINGAPORE, Sept. 30, 2021 /PRNewswire/ -- ABM Respiratory Care, a medical technology company focused on developing and globally commercializing novel integrated airway clearance and ventilation solutions, announced today the appointment of Amy Salzhauer and Greg Miller to the company's Board of Directors.  Ms. Salzhauer currently serves as a Founder and Managing Partner at Good Growth Capital (GGC), an early-stage venture capital firm known for its exceptional expertise in finding, cultivating, and assessing complex science and technology start-ups based in Charleston, SC and Boston, MA.  Mr. Miller recently retired as Executive Vice President and Chief Information Officer of Genuine Parts C

      9/30/21 8:39:00 AM ET
      $GPC
      $HRC
      $NWL
      Automotive Aftermarket
      Consumer Discretionary
      Medical/Dental Instruments
      Health Care
    • Stacy Enxing Seng Joins the Vesper Medical Board of Directors

      WAYNE, Pa.--(BUSINESS WIRE)--Vesper Medical, Inc., a developer of medical devices for deep venous disease, today announced that Stacy Enxing Seng has joined the board of directors effective immediately. An accomplished executive leader, Stacy has over 25 years in sales, marketing and operational leadership roles building innovative technology portfolios, demonstrated clinical outcomes, exceptional management teams and world-class company cultures. She has been recognized as one of the Top 100 Women in Business and is a frequent speaker on healthcare, innovation leadership and corporate culture. She currently serves as a venture partner for Lightstone Ventures and since 2013 has a

      1/4/21 7:30:00 AM ET
      $LIVN
      $HRC
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
      Medical/Dental Instruments

    $HRC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Hill-Rom Holdings downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded Hill-Rom Holdings from Overweight to Equal-Weight and set a new price target of $156.00 from $148.00 previously

      9/20/21 5:05:49 AM ET
      $HRC
      Medical/Dental Instruments
      Health Care
    • Hill-Rom Holdings downgraded by Keybanc

      Keybanc downgraded Hill-Rom Holdings from Overweight to Sector Weight

      9/8/21 4:28:39 AM ET
      $HRC
      Medical/Dental Instruments
      Health Care
    • Hill-Rom Holdings downgraded by Baird with a new price target

      Baird downgraded Hill-Rom Holdings from Outperform to Neutral and set a new price target of $156.00 from $150.00 previously

      9/3/21 6:14:37 AM ET
      $HRC
      Medical/Dental Instruments
      Health Care

    $HRC
    SEC Filings

    See more
    • SEC Form 15-12B filed by Hill-Rom Holdings Inc

      15-12B - Hill-Rom Holdings, Inc. (0000047518) (Filer)

      12/23/21 9:20:51 AM ET
      $HRC
      Medical/Dental Instruments
      Health Care
    • SEC Form 10-K/A filed by Hill-Rom Holdings Inc (Amendment)

      10-K/A - Hill-Rom Holdings, Inc. (0000047518) (Filer)

      12/23/21 9:18:07 AM ET
      $HRC
      Medical/Dental Instruments
      Health Care
    • SEC Form S-8 POS filed by Hill-Rom Holdings Inc

      S-8 POS - Hill-Rom Holdings, Inc. (0000047518) (Filer)

      12/13/21 5:09:05 PM ET
      $HRC
      Medical/Dental Instruments
      Health Care

    $HRC
    Financials

    Live finance-specific insights

    See more
    • Hillrom Exceeds Fourth Quarter Guidance With Strong Finish To Fiscal Year

      CHICAGO, Nov. 5, 2021 /PRNewswire/ -- Hillrom (NYSE:HRC) today announced financial results for its fiscal fourth quarter and full-year ended September 30, 2021. For the fiscal fourth quarter, Hillrom reported GAAP earnings of $0.80 per diluted share, an increase of 27 percent compared to $0.63 per diluted share in the prior-year period. On an adjusted basis, excluding special items, earnings of $1.67 per diluted share increased 43 percent and exceeded the company's previously-issued guidance range of $1.44 to $1.48 per diluted share. Adjustments to reported earnings are detail

      11/5/21 6:59:00 AM ET
      $HRC
      Medical/Dental Instruments
      Health Care
    • Hillrom Declares Quarterly Dividend

      CHICAGO, Nov. 2, 2021 /PRNewswire/ -- Hillrom (NYSE:HRC) announced today that its board of directors declared a quarterly dividend of $0.24 per share payable on December 31, 2021, to shareholders of record as of the close of business on December 15, 2021. The indicated annual dividend rate is $0.96 per share. About HillromHillrom is a global medical technology leader whose 10,000 employees have a single purpose: enhancing outcomes for patients and their caregivers by Advancing Connected Care™. Around the world, our innovations touch over 7 million patients each day. They help

      11/2/21 6:59:00 AM ET
      $HRC
      Medical/Dental Instruments
      Health Care
    • SV Health Investors Announces Three Realizations in its Growth Equity Portfolio

      BOSTON, Aug. 19, 2021 /PRNewswire/ -- SV Health Investors ("SV"), a leading global health care investment firm, is pleased to announce a series of realizations from its growth equity portfolio: On August 6, HillRom (NYSE:HRC) completed the acquisition of SV's portfolio company Bardy Diagnostics ("BDx"). In 2016, SV partnered with founder Dr. Gust Bardy to support the commercial launch of the Carnation Ambulatory Monitor, a best-in-class ambulatory cardiac monitor. The CAM offers both superior patient convenience and improved data capture. During the course of SV's partnership with BDx, the company built an increasingly sophisticated services capability and grew revenue ten-fold.  SV wishes t

      8/19/21 6:30:00 AM ET
      $BVS
      $HRC
      Medical/Dental Instruments
      Health Care